Capitanio U - Search Results

1

Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.

Campi R, Stewart GD, Staehler M, Dabestani S, Kuczyk MA, Shuch BM, Finelli A, Bex A, Ljungberg B, Capitanio U. Campi R, et al. Among authors: capitanio u. Eur Urol Oncol. 2021 Feb;4(1):22-41. doi: 10.1016/j.euo.2020.12.011. Epub 2021 Jan 3. Eur Urol Oncol. 2021. PMID: 33408053 Review.

2

Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.

Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, Briganti A, Gallina A, Capitanio U, Colombo R, Giorgio G, Montorsi F, Rigatti P. Roscigno M, et al. Among authors: capitanio u. Eur Urol. 2008 Apr;53(4):794-802. doi: 10.1016/j.eururo.2008.01.008. Epub 2008 Jan 15. Eur Urol. 2008. PMID: 18207313

3

Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.

Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F. Capitanio U, et al. Eur Urol. 2008 Jul;54(1):118-25. doi: 10.1016/j.eururo.2008.02.018. Epub 2008 Feb 26. Eur Urol. 2008. PMID: 18314255

4

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Chun FK, Suardi N, Capitanio U, Jeldres C, Ahyai S, Graefen M, Haese A, Steuber T, Erbersdobler A, Montorsi F, Huland H, Karakiewicz PI. Chun FK, et al. Among authors: capitanio u. Eur Urol. 2009 Mar;55(3):617-28-6. doi: 10.1016/j.eururo.2008.04.099. Epub 2008 May 15. Eur Urol. 2009. PMID: 18499335

5

A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma.

Karakiewicz PI, Suardi N, Capitanio U, Jeldres C, Ficarra V, Cindolo L, de la Taille A, Tostain J, Mulders PF, Bensalah K, Artibani W, Salomon L, Zigeuner R, Valéri A, Descotes JL, Rambeaud JJ, Méjean A, Montorsi F, Bertini R, Patard JJ. Karakiewicz PI, et al. Among authors: capitanio u. Eur Urol. 2009 Feb;55(2):287-95. doi: 10.1016/j.eururo.2008.07.037. Epub 2008 Jul 25. Eur Urol. 2009. PMID: 18715700

6

Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.

Capitanio U, Zini L, Perrotte P, Shariat SF, Jeldres C, Arjane P, Pharand D, Widmer H, Péloquin F, Montorsi F, Patard JJ, Karakiewicz PI. Capitanio U, et al. Urology. 2008 Nov;72(5):1090-5. doi: 10.1016/j.urology.2008.06.059. Epub 2008 Sep 16. Urology. 2008. PMID: 18799207

7

Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.

Zini L, Capitanio U, Perrotte P, Jeldres C, Shariat SF, Arjane P, Widmer H, Montorsi F, Patard JJ, Karakiewicz PI. Zini L, et al. Among authors: capitanio u. Urology. 2009 Feb;73(2):342-6. doi: 10.1016/j.urology.2008.09.022. Epub 2008 Nov 28. Urology. 2009. PMID: 19041122

8

Thirty-day mortality after nephrectomy: clinical implications for informed consent.

Cloutier V, Capitanio U, Zini L, Perrotte P, Jeldres C, Shariat SF, Arjane P, Patard JJ, Montorsi F, Karakiewicz PI. Cloutier V, et al. Among authors: capitanio u. Eur Urol. 2009 Dec;56(6):998-1003. doi: 10.1016/j.eururo.2008.11.023. Epub 2008 Nov 25. Eur Urol. 2009. PMID: 19054604

9

Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.

Jeldres C, Patard JJ, Capitanio U, Perrotte P, Suardi N, Crepel M, Ficarra V, Cindolo L, de La Taille A, Tostain J, Pfister C, Albouy B, Colombel M, Méjean A, Lang H, Jacqmin D, Bernhard JC, Ferrière JM, Bensalah K, Karakiewicz PI. Jeldres C, et al. Among authors: capitanio u. Urology. 2009 Jun;73(6):1300-5. doi: 10.1016/j.urology.2008.08.492. Epub 2009 Apr 18. Urology. 2009. PMID: 19376568

10

The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Sagalowsky A, Bensalah K, Raman JD, Bolenz C, Kassou W, Koppie TM, Wood CG, Wheat J, Langner C, Ng CK, Capitanio U, Bertini R, Fernández MI, Mikami S, Isida M, Ströbel P, Montorsi F. Roscigno M, et al. Among authors: capitanio u. Eur Urol. 2009 Sep;56(3):512-8. doi: 10.1016/j.eururo.2009.06.004. Epub 2009 Jun 18. Eur Urol. 2009. PMID: 19559518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page